Navigation Links
BellBrook Labs Publishes “A Guide to Measuring Drug-Target Residence Times with Biochemical Assays”
Date:8/31/2018

In recent years researchers have been increasing efforts to measure inhibitor residence times as a component of drug discovery programs. Longer-target engagement can result in improved efficacy and reduced side effects. Other methods of deriving these residence times are low throughput, require expensive instrumentation, or require the alteration of the molecules involved. The limitations of these methods make it challenging to prioritize compounds within the time constraints of a drug discovery program. The ability to effectively measure drug-target residence time in a high throughput format gives scientists the tools to effectively prioritize lead compounds and improve success rates in the earlier stages of drug discovery.

The guide details the jump-dilution approach to measuring residence time and compares it to other approaches, such as surface plasmon resonance, biolayer interferometry, and resonant acoustic profiling. This article also describes a universal high throughput screening (HTS) compatible assay method broadly applicable to a variety of targets such as kinases, phosphodiesterases (PDEs), and glycosyltransferases (GTFs) using the Transcreener Assay Platform.

The guide provides a step-by-step protocol with examples and case studies that walk a user through the process of both accurately determining resonance time and using a rank order approach amiable to HTS. A comparison of Transcreener’s three fluorescent readouts fluorescence polarization (FP), fluorescence intensity (FI), and TR-FRET gives the researcher multiple options within a suite of drug discovery tools.

In the guide you can discover:

  •     The basics of residence time and its importance to drug discovery
  •     A comparison of methods used for residence time determination
  •     Using the jump-dilution method with Transcreener biochemical assays
  •     Data analysis used to accurately measure residence time
  •     Examples of measuring inhibitor residence time for kinases, PDEs, and GTFs

Please visit bellbrooklabs.com to download the free residence time guide.

About BellBrook Labs:

BellBrook Labs is dedicated to accelerating drug discovery and biological research by providing innovative high throughput screening solutions. BellBrook’s core technology, Transcreener, is a universal, homogenous biochemical assay platform based on detection of nucleotides that makes it easy to screen thousands of different enzymes. These include validated targets like kinases and phosphodiesterases, as well as emerging targets like ATPases, GTPases, methyltransferases, and glycosyltransferases. Detection reagents from BellBrook Labs help researchers progress toward more effective therapies for cancer and other debilitating diseases.

Read the full story at https://www.prweb.com/releases/bellbrook_labs_publishes_a_guide_to_measuring_drug_target_residence_times_with_biochemical_assays/prweb15725311.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout
2. BellBrook Labs Launches New Streamlined Website
3. Elseviers Maturitas publishes clinical guide on endometrial assessment in postmenopausal women
4. Reproductive BioMedicine Online publishes study on assisted reproduction
5. American Academy of Microbiology publishes West Nile virus report
6. Journal of Spinal Cord Medicine publishes special issue on assistive technology
7. Genetics in Medicine publishes special issue dedicated to genomics in electronic health records
8. Elseviers Maturitas publishes position statement on fertility preservation
9. Wellspring Biosciences Founder Publishes In Nature On Discovery of Small Molecule Inhibitors of K-Ras
10. EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus
11. Open science journal publishes attempt to reproduce high-profile stem cell acid bath study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2018)... Calif. (PRWEB) , ... August 21, 2018 , ... ... engineer the genomes of diverse cell types and species for the robust functional ... research tool for the development of T-cell based immunotherapies, the study of the ...
(Date:8/23/2018)... ... ... is proud to have hosted a variety of groups this year – both new guests ... Hewlett Packard, Sequenom and more, have all visited the La Jolla-based venue time and time ... reason clientele return is due to Lajollacooks4u’s signature team-building format, a way for teams to ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... for biopharma R&D, today announced that Seattle-based Aptevo Therapeutics , a ... Aptevo will use the Genedata Biologics ® platform to facilitate expansion ...
Breaking Biology News(10 mins):
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more ... and getting connected, too. Draper’s latest system is tiny in size, but is poised ... driving factor in the new implant design is the growing awareness that disease often ...
(Date:8/29/2018)... ... August 28, 2018 , ... Inc. Magazine has announced that ... in 1138th place on the 27th annual Inc. 5000, the most prestigious ranking ... most successful companies within the American economy’s most dynamic segment – independent small ...
(Date:8/29/2018)... SANTA BARBARA, Calif. (PRWEB) , ... August 28, 2018 , ... ... process optimization firm for the life sciences and healthcare industries, announces that Manu Vohra ... CA on August 30th. , What: “How to Implement Box for GxP in ...
(Date:8/23/2018)... , ... August 22, 2018 , ... ... for Android on September 1st, making it the first fully-featured app for electronic ... Android devices. Combined, iOS and Android constitute 99 percent of the market share ...
Breaking Biology Technology: